Synthetic Biologics, Inc. (SYN)
EBITDA
-$9.67M
TTM · Period ending: · USD
SYN EBITDA
Latest reported-$9.67Mperiod ending
Latest reported-$9.67Mperiod ending
SYN EBITDA (-$1.94M → -$9.67M)
Annual EBITDA
High-resolution chart · PNG
SYN ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -24,051,000 | |
| 137,000 | |
| -21,496,000 | |
| -14,174,000 | |
| -9,842,000 | |
| -15,063,000 | |
| -13,095,000 | |
| -14,929,000 | |
| -27,098,000 | |
| -43,665,000 | |
| -19,764,000 | |
| -12,274,000 | |
| -17,005,000 | |
| -7,948,000 | |
| -1,342,343 | |
| -3,339,437 | |
| -6,786,704 | |
| -9,692,804 | |
| -4,068,420 | |
| -1,353,582 | |
| 15,390,000 | |
| -8,771,710 | |
| -9,609,691 | |
| -5,881,926 | |
| -17,471,129 | |
| -18,700,000 | |
| -9,600,000 | |
| -7,100,000 | |
| -7,300,000 | |
| -6,300,000 | |
| -4,000,000 | |
| -1,940,000 |